Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02520323 · ClinicalTrials.gov registry record
The Lung Microbiome in Sarcoidosis
A clinical trial, sponsored by University of Michigan.
- Completed
- Registry status
- 21
- Enrollment target
NCT02520323: Completed study, sponsored by University of Michigan.
NCT02520323 is a clinical trial that has completed, run by University of Michigan. The registered enrollment target is 21 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02520323 has completed, sponsored by University of Michigan.
- COMPLETED
- Registry status
- 21 participants
- Enrollment target
Study Summary
The objective of this study is to determine the presence of bacterial species, and the immunologic and molecular mechanisms of granuloma formation that might be involved in the pathogenesis of sarcoidosis. The investigators will collect peripheral blood and bronchoalveolar lavage fluid samples to isolate bacterial DNA and blood monocytes and lymphocytes. Specimens will be obtained from patients with sarcoidosis, with non-sarcoid lung disease, and healthy volunteers to directly compare the bacterial species present and the characteristics of cells thought to be involved in granuloma formation.
Primary Outcome
To assess the microbiome profile in lung lavage fluid and peripheral blood of subjects
Interventions
- OTHER Blood draw
- BEHAVIORAL Questionnaires
- PROCEDURE Bronchoscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-06 |
What the finished NCT02520323 record still lists
NCT02520323 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 21 participants, a relatively small participant target.
The record links to 0 conditions, and to 3 interventions - of which Blood draw is the first listed.
NCT02520323 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02520323 about?
NCT02520323 is a clinical study titled "The Lung Microbiome in Sarcoidosis". The objective of this study is to determine the presence of bacterial species, and the immunologic and molecular mechanisms of granuloma formation that might be involved in the pathogenesis of sarcoidosis. The investigators will collect peripheral blood and bronchoalveolar lavage fluid samples to is...
What is the current status of trial NCT02520323?
This trial is currently completed. The enrollment target is 21 participants. The study started on 2015-06. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02520323?
The interventions under investigation include: Blood draw (OTHER), Questionnaires (BEHAVIORAL), Bronchoscopy (PROCEDURE).
Who is sponsoring clinical trial NCT02520323?
This trial is sponsored by University of Michigan, which has 1,327 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02447874 · 21 participants · Phase 1
Arginine Therapy for the Treatment of Pain in Children With Sickle Cell Disease
- NCT03826992 · 21 participants · Phase 1
Venetoclax Combined With Vyxeos (CPX-351) for Participants With Relapsed or Refractory Acute Leukemia
- NCT04107077 · 21 participants · Phase 2
Phase II Study of the Effects of Laparoscopic Hyperthermic Intraperitoneal Chemotherapy (HIPEC) in Patients With Advanced Gastric Cancer
- NCT04158635 · 21 participants · Phase 1
Gemcitabine, Nab-Paclitaxel, and Bosentan for the Treatment of Unresectable Pancreatic Cancer
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia